Search Ontology:
ChEBI
XMU-MP-1
- Term ID
- CHEBI:231615
- Synonyms
-
- 4-((5,10-dimethyl-6-oxo-6,10-dihydro-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino)benzenesulfonamide
- 4-[(5,10-dimethyl-6-oxo-6,10-dihydro-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]benzenesulfonamide
- XMU MP 1
- XMU-MP1
- Definition
- An organic heterotricyclic compound that is 5,10-dihydro-6H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-6-one substituted by (4-sulfamoylphenyl)amino, methyl and methyl groups at positions 2, 5 and 10, respectively. It is an inhibitor of the Hippo pathway kinases MST1 and MST2 (IC50 = 71.1 and 38.1 nM, respectively).
- References
-
- cas:2061980-01-4
- pubmed:27535619
- pubmed:30806090
- pubmed:31328787
- pubmed:32973917
- pubmed:32987643
- pubmed:33887258
- pubmed:34007939
- pubmed:35088536
- pubmed:35123978
- pubmed:35731253
- pubmed:36199358
- pubmed:36495715
- pubmed:37251938
- pubmed:37277791
- pubmed:37551490
- pubmed:37661231
- pubmed:37882715
- pubmed:38043154
- pubmed:38760516
- pubmed:38965852
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from XMU-MP-1
Phenotype where environments contain XMU-MP-1
Phenotype modified by environments containing XMU-MP-1
Phenotype affecting XMU-MP-1
Human Disease Model